Elephant endotheliotropic herpesvirus (EEHV) is a type of herpesvirus that causes acute hemorrhagic disease in Asian elephants (Elephas maximus) and is often fatal, especially in calves. This study describes the postmortem evaluation of two captive-born Asian elephants (2 and 3 yr of age, respectively) diagnosed with EEHV in Thailand. Both elephants presented only mild depression, lethargy, and anorexia before death within 24 hr of symptom onset. Necropsies were performed, and tissue samples were tested for EEHV viral presence using polymerase chain reaction. Molecular and phylogenetic evidence illustrated two types of EEHV, which were closely related to EEHV1A in Case 1 and EEHV4 in Case 2. Pathologic findings differed between the cases. More specific organ tropism was found in Case 1, where mainly the cardiovascular system was affected. In contrast, in Case 2, hemorrhages were noted in most organs, including in the gastrointestinal, respiratory, and cardiovascular systems. This report is the first to document EEHV4 in Asia and the second case of this strain to be identified in an elephant worldwide.
The elephant endotheliotropic herpesvirus (EEHV) has been a known cause of death of young elephants in Thailand for over a decade. In this study, we report on the demography, disease characteristics and mortality of 58 elephants with confirmed EEHV hemorrhagic disease between January 2006 and August 2018 using retrospective data subjected to survival analysis. Median age of EEHV presentation was 29 months, and the mortality rate was 68.97% with a median survival time of 36 h. Most EEHV cases occurred in the north of Thailand, the region where most of the country’s captive elephants reside. The hazard ratio analysis identified application of medical procedures and antiviral medications as being significant factors correlated to the risk of death. Our results indicate a need to focus EEHV monitoring efforts on young elephants and to follow current protocols that advise starting treatments before clinical signs appear.
Haemorrhagic septicemia (HS) is a contagious disease in cattle with high morbidity and mortality rates. HS vaccine in Thailand is an oil-adjuvant formulation, and is difficult to administer. The present study aimed to
formulate and evaluate the protection in dairy calves conferred by immunization with an in-house intranasal HS vaccine. The intranasal vaccine was formulated in a total volume of 500 µl containing either
50 or 100 µg of the recombinant outer membrane protein H (rOmpH) of Pasteurella multocida strain M-1404 (serovar B:2), and 10 µg of Cytosine-phosphate-guanosine
oligodeoxynucleotides (CpG-ODN) as a mucosal adjuvant. Intranasal immunizations were conducted three times at three-week intervals. The antibodies post-immunization were detected by indirect ELISA and demonstrated
efficient in vitro activity in suppressing a P. multocida strain from the complement-mediated killing assay. An intranasal vaccine induced both the serum IgG and secretory IgA levels
that were significantly higher than the level conferred by the parenteral vaccine (P<0.05). Challenge exposure was conducted with a P. multocida strain M-1404 at day 72 of the
experiments. The immunized calves had reduced clinical signs after challenge exposure that would normally result in disease proliferation. We conclude that intranasal vaccination of calves with rOmpH with CpG-ODN 2007
stimulated serum and secretory antibodies to rOmpH and whole cells of P. multocida strain M-1404 antigen. Moreover, it would result in protection in calves against artificial P.
multocida infection.
Recombinant outer membrane protein H (rOmpH) is a potential fowl cholera vaccine
candidate. The present study was aimed at developing rOmpH formulations for intranasal
administration. The rOmpH was purified and formulated with either Escherichia
coli enterotoxin B (LTB) or CpG oligodeoxynucleotides (ODN) as an adjuvant.
Antibody responses in chickens intranasally immunized with rOmpH in combination with 2
different adjuvants were significantly increased (P<0.05) post
immunization. Chicken survival rates showed that rOmpH formulated with ODN and LTB
elicited 90% and 70% protection, respectively. Our findings indicated that rOmpH
formulated with ODN elicited protection better than that formulated with LTB. Therefore,
the vaccines formulations in the present study can be considered new intranasal vaccine
formulations for fowl cholera in chickens.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.